Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 20/20 | 0.74 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.74 |
| ▸ | CCR5 | P51681 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6802196 | 1.00 | CCR1 (0.74) | CCR1CHRM2CCR5 | |
| SCHEMBL6250176 | 0.93 | CCR1 (0.81) | CCR1CHRM2CCR5 | |
| SCHEMBL6248515 | 0.91 | CCR1 (0.73) | CCR1CHRM2CCR5 | |
| SCHEMBL6248481 | 0.91 | CCR1 (0.73) | CCR1CHRM2CCR5 | |
| SCHEMBL6248484 | 0.91 | CCR1 (0.73) | CCR1CHRM2CCR5 | |
| SCHEMBL6248509 | 0.91 | CCR1 (0.73) | CCR1CHRM2CCR5 | |
| SCHEMBL6248479 | 0.91 | CCR1 (0.73) | CCR1CHRM2CCR5 | |
| SCHEMBL6250205 | 0.90 | CCR1 (0.72) | CCR1CHRM2CCR5 | |
| SCHEMBL6250195 | 0.90 | CCR1 (0.72) | CCR1CHRM2CCR5 | |
| SCHEMBL6250202 | 0.90 | CCR1 (0.72) | CCR1CHRM2CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040097554-A1 | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents | PFIZER INC | 2004-05-20 | — | — | US | claimed |
| US-20040097554-A1 | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents | PFIZER INC | 2004-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097554-A1 | Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents | CCR1, HCAR1, CCR3 | CCR1 1/4885CHRM2 143/4885CCR5 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.